Therapy of respiratory syncytial virus infection

Pediatr Infect Dis J. 2000 Aug;19(8):786-90; discussion 802-4, 811-3. doi: 10.1097/00006454-200008000-00032.
No abstract available

Publication types

  • Case Reports
  • Review

MeSH terms

  • Antiviral Agents / therapeutic use*
  • Child
  • Child, Preschool
  • Controlled Clinical Trials as Topic
  • Female
  • Humans
  • Immunocompromised Host*
  • Infant
  • Male
  • Prognosis
  • Respiratory Syncytial Virus Infections / drug therapy*
  • Respiratory Syncytial Virus Infections / immunology*
  • Respiratory Syncytial Virus Infections / mortality
  • Ribavirin / therapeutic use*
  • Risk Assessment
  • Survival Rate
  • Viral Load

Substances

  • Antiviral Agents
  • Ribavirin